SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Malcangi, G
Right arrow Articles by Danieli, M G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malcangi, G
Right arrow Articles by Danieli, M G
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bullous SLE: response to methotrexate and relationship with disease activity

G Malcangi

Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, Torrette di Ancona, Italy

G Brandozzi

Divisione di Dermatologia, Torrette di Ancona, Italy

M Giangiacomi

Istituto di Anatomia Patologica dell’Universitàdegli Studi di Ancona, Torrette di Ancona, Italy

M Zampetti

Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, Torrette di Ancona, Italy

M G Danieli

Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, Torrette di Ancona, Italy, eleonora{at}popcsi.unian.it

We report on a case of 40-year-old female with systemic lupus erythematosus (SLE) who developed a severe bullous eruption on sun-exposed areas. The bullous manifestation was associated with a flare of lupus serologies, whereas the previous manifestations of the disease were quiescent. Due to prior intolerance to many drugs, she was given oral methotrexate (10 mg=week). The drug administration was followed by a rapid and full resolution of cutaneous lesions. Five months later she developed a class III lupus nephritis. Our case is the first report of efficacy of methotrexate in bullous SLE and rises the question of the relationship between bullous eruption and SLE activity.

Key Words: systemic lupus erythematosus • bullous manifestation • skin • methotrexate

Lupus, Vol. 12, No. 1, 63-66 (2003)
DOI: 10.1191/0961203303lu241cr


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement